Timo Muhonen
Impact in
- Oncology top 5%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
Papers in
- Oncology 34
- Cutaneous Melanoma Detection and Management 12
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 5
- Immunology 15
- Immunotherapy and Immune Responses 14
- Immune Cell Function and Interaction 4
- Co-authors
- Seppo Pyrhönen (24 shared papers)Marjo Hahka‐Kemppinen (10 shared papers)Ismo T. Jantunen (5 shared papers)Vesa Kataja (3 shared papers)Micaela Hernberg (10 shared papers)Juha Pekka Turunen (5 shared papers)Tatyana Vlaykova (5 shared papers)T. Koskinen (1 shared paper)
In The Last Decade
Timo Muhonen
52 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 102
- Oncology 457
- Immunology and Allergy 98
- Biological Psychiatry 30
- Ophthalmology 89
- Immunology 193
Countries citing papers authored by Timo Muhonen
This map shows the geographic impact of Timo Muhonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Muhonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Muhonen more than expected).
Fields of papers citing papers by Timo Muhonen
This network shows the impact of papers produced by Timo Muhonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Muhonen. The network helps show where Timo Muhonen may publish in the future.
Co-authors
The 25 scholars most cited alongside Timo Muhonen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 113 | |
| 2 | 1992 | 80 | |
| 3 | 1993 | 77 | |
| 4 | 1997 | 64 | |
| 5 | 2002 | 63 | |
| 6 | A low proportion of BRCA2 mutations in Finnish breast cancer families. | 1997 | 59 |
| 7 | 1999 | 56 | |
| 8 | 1998 | 38 | |
| 9 | 1999 | 37 | |
| 10 | 1996 | 37 | |
| 11 | 1995 | 33 | |
| 12 | 1996 | 32 | |
| 13 | 1998 | 29 | |
| 14 | 2004 | 29 | |
| 15 | 2002 | 28 | |
| 16 | 1996 | 28 | |
| 17 | 1996 | 28 | |
| 18 | 1999 | 27 | |
| 19 | 1997 | 25 | |
| 20 | 1997 | 25 |
About Timo Muhonen
Timo Muhonen is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (14 papers), Cutaneous Melanoma Detection and Management (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cell Adhesion Molecules Research (7 papers), Cancer Genomics and Diagnostics (7 papers), CAR-T cell therapy research (5 papers), Melanoma and MAPK Pathways (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Oncology (457 citations), Immunology and Allergy (98 citations), Biological Psychiatry (30 citations), Ophthalmology (89 citations) and Immunology (193 citations). Timo Muhonen has collaborated with scholars based in Finland, Sweden and Bulgaria. Frequent co-authors include Seppo Pyrhönen, Marjo Hahka‐Kemppinen, Ismo T. Jantunen, Vesa Kataja, Micaela Hernberg, Juha Pekka Turunen, Tatyana Vlaykova, T. Koskinen, Björn Appelberg and Erkka Syvälahti. Their work appears in journals such as European Journal of Cancer, Melanoma Research, Annals of Oncology, Journal of Immunotherapy and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.